Table 4. Prognostic prediction by Kapplan–Meier survival analyses.
Factors | 3–year OS (%) | 5–year OS (%) | MS (months) | AIC | C–index | Log rank χ2 value | P |
---|---|---|---|---|---|---|---|
N stage | 898.7 | 0.687 | 151.1 | < 0.001 | |||
N0 | 85.2 | 72.5 | 124.1 (7.5–176.0) | ||||
N1 | 76.1 | 63.4 | 113.0 (3.5–174.0) | ||||
N2 | 67.1 | 52.8 | 99.5 (1.4–172.4) | ||||
N3a | 42.3 | 27.5 | 29.9 (0.9–160.0) | ||||
N3b | 26.5 | 20.4 | 23.0 (0.3–172.7) | ||||
Nr stage | 880.1 | 0.696 | 156.7 | < 0.001 | |||
Nr0 | 85.2 | 72.5 | 124.1 (7.5–176.0) | ||||
Nr1 | 78.3 | 63.4 | 106.0 (1.4–160.0) | ||||
Nr2 | 58.4 | 46.9 | 54.9 (0.3–174.0) | ||||
Nr3 | 30.4 | 22.6 | 26.1 (0.9–172.7) | ||||
TNM stage | 872.3 | 0.754 | 161.7 | < 0.001 | |||
IA | 92.6 | 82.5 | 134.2 (9.3–156.2) | ||||
IB | 87.3 | 77.2 | 121.2 (1.4–172.4) | ||||
IIA | 81.1 | 71.6 | 101.3 (0.3–174.0) | ||||
IIB | 79.8 | 60.6 | 92.7 (4.0–176.0) | ||||
IIIA | 66,2 | 55.4 | 82.6 (5.4–157.2) | ||||
IIIB | 55.9 | 46.2 | 46.6 (0.9–150.3) | ||||
IIIC | 33.1 | 22.2 | 25.4 (0.8–172.7) | ||||
TNrM stage | 850.4 | 0.799 | 182.3 | < 0.001 | |||
IA | 92.6 | 82.5 | 134.2 (9.3–165.2) | ||||
IB | 90.4 | 80.8 | 112.5 (6.5–176.0) | ||||
IIA | 85.0 | 73.4 | 98.4 (1.4–160.9) | ||||
IIB | 79.5 | 61.8 | 84.6 (0.3–173.1) | ||||
IIIA | 64.3 | 57.0 | 65.4 (0.8–161.8) | ||||
IIIB | 56.4 | 41.3 | 47.3 (0.9–175.6) | ||||
IIIC | 30.2 | 22.4 | 24.0 (0.6–172.3) |
OS: overall survival ; MS: median survival time; AIC: Akaike Information Criterion value; C–index: concordance index.